CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We have now added a new section called the "Assay History List" to the "At A Gla...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...